Meet our team at booth #1522 during the BioProcess International Conference and Exhibition, in Boston (USA), September 4th-7th, 2018.
Our solutions for both protein and virus production
FectoPRO® Transfection kit is specifically designed for enhanced Transient Gene Expression (TGE) in suspension CHO and HEK-293 cells in various serum-free media, using low DNA amount (< 1 µg/ml of cell culture).
FectoCHO™ Expression system is a 3 component kit optimized to work together that contains FectoCHO™ CD Medium, FectoPRO® Transfection Reagent and FectoPRO® Expression Booster. FectoCHO™ Expression System has been developed to reach the highest protein production ever seen in CHO cell lines.
PEIpro® is a DNA transfection reagent for production of viruses, recombinant proteins and antibodies either in adherent cells in presence of serum or in suspension HEK-293 cells grown in low serum or serum-free media.
PEIpro®-HQ is a highly qualified grade of PEIpro® reagent, especially developed for the production of clinical batches of recombinant proteins, antibodies or viral vectors. The PEIpro®-HQ grade is supplied with appropriate Quality Controls and documentation allowing its use as a qualified raw material in GMP processes for the manufacturing of clinical batches of therapeutic products.
The convention will take place at the Hynes Convention Center Boston:
900 Boylston St, Boston, MA 02115, USA.
Meet Géraldine Guerin-Peyrou and Julien Depollier to discuss how to improve your process of Bioproduction. We will be happy to answer all your questions regarding transfection and to present relevant products adapted to protein or virus production.
| Géraldine Guerin-Peyrou|
Marketing & Technical support Director
Business Director – Americas
Join us on social networks
We created a dedicated event on Facebook to allow you to discuss with other scientists about the BioProcess International meeting or about your transfection experiments.
If you want to talk about this event (Facebook, Twitter, Google+, etc…), don’t forget to use the #BPIWest and follow the BioProcess International news.